Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.10
18.08.20
-
04.11.21
-12.10%
11.11.20

Could be worthwhile Investment >10% per year
Capable Management
Innovative
Market Leader or Top 3
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€321.10
15.08.20
-
16.10.20
12.64%
16.10.20

EBIT growth >5% per year expected
Very low/no dividend yield expected
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€85.17
14.08.20
€120.00
04.11.21
31.44%
05.11.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth > 30% per year expected
buy
Medtronic plc

Start price
Target price
Perf. (%)
€85.25
10.08.20
-
04.11.21
22.82%
05.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Normal challenges to pay loans and raise capital
ROE higher than 15% per year
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.72
09.08.20
€65.00
26.08.20
-5.53%
26.08.20

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
04.08.20
€38.00
04.11.21
0.31%
13.04.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Small cyclical dependencies
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€89.92
30.07.20
€125.00
04.11.21
44.97%
21.01.21

Very capable Management
Very good company culture
Leading role in innovation
Could be very worthwhile Investment >20% year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.70
16.07.20
€33.21
25.08.20
4.15%
25.08.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.65
12.07.20
-
17.10.20
9.93%
17.10.20

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€28.84
01.07.20
€42.69
08.07.20
-2.30%
08.07.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Baxter International

Start price
Target price
Perf. (%)
€77.61
01.07.20
€80.00
04.11.21
-12.10%
05.11.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Small cyclical dependencies
Known brand
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€49.48
19.06.20
€55.00
04.11.21
12.05%
04.04.21

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
High dividend yield expected
Good rating
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.87
08.06.20
€65.00
04.11.21
-18.67%
05.11.21

Could be worthwhile Investment >10% per year
Capable Management
Top 10 in its market
Known brand
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
06.06.20
€205.00
04.11.21
77.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€264.80
05.06.20
€290.00
12.10.20
5.70%
12.10.20

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€66.80
20.05.20
€60.00
25.05.20
4.09%
25.05.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Anthem Inc.

Start price
Target price
Perf. (%)
€248.65
04.05.20
€275.00
12.10.20
1.45%
12.10.20

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.59
03.05.20
€90.00
04.11.21
-25.71%
05.11.21

Gilead Sciences Inc

Start price
Target price
Perf. (%)
€76.31
30.04.20
€55.00
04.11.21
-24.47%
05.11.21

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.45
30.04.20
€85.00
04.05.20
-5.28%
04.05.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.15
29.04.20
€90.00
04.11.21
-25.29%
05.11.21

buy
Centene Corp.

Start price
Target price
Perf. (%)
€63.00
28.04.20
€75.00
04.11.21
2.38%
05.11.21

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.99
24.04.20
€85.00
04.11.21
-21.03%
05.11.21

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€275.40
22.04.20
€320.00
04.11.21
17.79%
17.06.21

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€86.80
20.04.20
€120.00
04.11.21
28.11%
04.11.21